Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

Journal of Infectious Diseases

Volumn 178, Issue 5 SUPPL., 1998, Pages 1257-1262

  Gubareva, Larisa V ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZANAMIVIR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS B; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; VIRUS ISOLATION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CELL LINE; CERCOPITHECUS AETHIOPS; DOGS; DRUG RESISTANCE, MICROBIAL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRETS; GUANIDINES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOSUPPRESSION; INFANT; INFLUENZA B VIRUS; INFLUENZA, HUMAN; LEUKEMIA, MYELOID, CHRONIC; MUTATION; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; PYRANS; RECEPTORS, VIRUS; RNA, VIRAL; SIALIC ACIDS; VERO CELLS; ZANAMIVIR;

EID: 0031724750     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314440     Document Type: Article

References (7)

1. Hayden FG. Amantadine and rimantadine-clinical aspects. In: Richman DD, ed. Antiviral drug resistance. John Wiley, 1996:59-77.
2. von Itzstein M, Wu WY, Kok GB, et al. Rational design of potent sialidasebased inhibitors of influenza virus protection. Nature 1993;363:418-23.
3. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 1996;275:295-9.
4. Hayden FG, Osterhaus ADME, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997; 337:874-80.
5. Gubareva LV, Bethell RC, Hart GJ, Murti KG, Penn CR, Webster RG. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J Virol 1996:70:1818-27.
6. Staschke KA, Colacino JM, Baxter AJ, et al. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 1995;214: 642-6.
7. Blick TJ, Tiong T, Sahasrabudhe A, et al. Generation and characterization of an influenza virus variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en. Virology 1998;214: 475-84.